Gujarat Alkalies & Chemicals Performance
- Today's Low
- ₹665
- Today's High
- ₹699
- 52 Week Low
- ₹409
- 52 Week High
- ₹815
- Open Price₹666
- Previous Close₹665
- Volume202,532
- 50 DMA₹662.37
- 100 DMA₹614.74
- 200 DMA₹592.00
Gujarat Alkalies & Chemicals Chart
Investment Returns
- Over 1 Month -16.26%
- Over 3 Month + 42.67%
- Over 6 Month + 28.8%
- Over 1 Year + 13.4%
Smart Investing Starts Here Start SIP with Gujarat Alkalies & Chemicals for Steady Growth!
Gujarat Alkalies & Chemicals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -2043.9
- PEG Ratio
- -21.2
- Market Cap Cr
- 4,926
- P/B Ratio
- 0.9
- Average True Range
- 33.47
- EPS
- 0
- Dividend Yield
- 2.4
- MACD Signal
- 5.58
- RSI
- 44.75
- MFI
- 57.54
Latest Stock News Updates
Commodity Chemicals company Gujarat Alkalies & Chemicals announced Q4FY26 & FY26 results Consolidated Financial Highlights: Total Income: Consolidated total income for Q4FY26 was Rs 1,14,370 Lakh, up by 6.40% from Q3FY26 (QoQ) and 3.98% from Q4FY25 (YoY). Profit After Tax (Net Profit): Consolidated net profit for Q4FY26 stood at Rs 1,498 Lakh, as against a net loss of Rs 1,995 Lakh in Q3FY26 (QoQ) and a net profit of Rs 882 Lakh in Q4FY25 (YoY), representing a YoY growth of 69.84% for the quarter. Annual Performance: For the full year FY26, the company significantly narrowed its consolidated net loss to Rs 241 Lakh, compared to a net loss of Rs 6,512 Lakh in FY25. Standalone Financial Highlights: Revenue from Operations: For Q4FY26, revenue reached Rs 1,12,531 Lakh, an increase of 7.74% from Rs 1,04,446 Lakh in Q3FY26 (QoQ) and a growth of 4.63% from Rs 1,07,547 Lakh in Q4FY25 (YoY). For the full year FY26, standalone revenue was Rs 4,35,808 Lakh, up by 7.00% from Rs 4,07,291 Lakh in FY25. Total Income: Total income for Q4FY26 stood at Rs 1,14,370 Lakh, reflecting a QoQ growth of 6.40% compared to Rs 1,07,493 Lakh and a YoY increase of 3.98% compared to Rs 1,09,990 Lakh. For the full year FY26, total income reached Rs 4,47,470 Lakh against Rs 4,16,505 Lakh in FY25. Profit After Tax (Net Profit): The company reported a net profit of Rs 793 Lakh for Q4FY26, compared to a net loss of Rs 1,116 Lakh in Q3FY26 (QoQ) and a net profit of Rs 2,138 Lakh in Q4FY25 (YoY). On an annual basis, the standalone net profit for FY26 grew by 31.73% to Rs 2,084 Lakh from Rs 1,582 Lakh in FY25. Earnings Per Share (EPS): Basic and diluted EPS for Q4FY26 was Rs 1.08. For the full year FY26, standalone basic EPS increased to Rs 2.84 from Rs 2.15 in FY25. Business Highlights: Dividend Recommendation: The Board of Directors has recommended a Final Dividend of Rs 17.70 per equity share (177%) of Rs 10 each for the financial year ended March 31, 2026. Segment Performance: The company operates under a single reportable segment, namely "Chemicals," as per Ind AS - 108. Expansion Project: The company has approved setting up a 5000 TPA (100%) Electronic Grade Hydrogen Peroxide Plant at Dahej, Gujarat, with an estimated investment of Rs 67 crore. The project is expected to contribute approximately Rs 42 crore to annual sales revenue upon commissioning in 18 months. Renewable Energy: During FY26, the share of renewable energy in the total power consumption basket increased to 35.7% from 29.7% in the previous year, aiding in the reduction of energy costs. Strategic Efficiency Initiatives: The company is driving "Project Ahvaan," which focuses on enhancing operating efficiency, cost-cutting, and optimum capacity utilization across various plants. Technology & AI: The Board approved the implementation of a digitization and AI strategy for the next two years, including the migration to SAP S/4HANA. Smt. Avantika Singh, IAS, Managing Director: "Sales Revenue for the Financial Year 2025-26 has increased by Rs 287 crore (i.e. by 7%) to Rs 4,246 crore as compared to Rs 3,959 crore of the Previous year. The Company successfully enhanced capacity utilization across plants and achieved higher production across major products and benefited from improved sales realizations in select products. EBITDA for the Financial Year 2025-26 has increased by Rs 69 crore (i.e. by 15%) to Rs 522 crore as compared to EBITDA of Rs 453 crore for the previous year. Energy is continued focus area for the company and during FY 2025-26 company could reduce energy cost as compared to previous year on account of increased share of renewable power. During the FY 2025-26, the share of renewable energy has increased to 35.7% from 29.7%. This aligns with the Board's directive to expand renewable power usage and supports India's net-zero carbon commitments. The Board has recommended a Dividend of 177% on equity Shares of Rs.10/- each. i.e. Rs.17.70/- per share payable partly from current year profit and partly from free reserves." She further said "The Board of Directors also approved putting up a 5000 TPA (100%) High Purity grade Hydrogen Peroxide plant at Dahej. This will enable the Company to serve the niche market in semiconductor, solar, electronic and other advanced applications. The Board also approved remembraning & recoating of generation VB+ Cell elements at Vadodara Complex. This will enable the Company to further reduce power cost as well as fulfil the requirement of Pl\ T (Perform, Achieve & Trade notified by the Government of India) to reduce the carbon footprint. The Board of Directors have also approved the implementation of digitization and AI strategy during next two years, including migration from SAP ECC to RISE with SAP S/4HANA." She further added "In the Current Financial Year 2026-27, the Company expects to commission HCI Synthesis Unit, Chloroto/uene Down Stream Plant, Caustic Soda Flaking Plant, Cell elements replacements and 138.60 MW Renewable energy projects. These initiatives would significantly improve both top and bottom lines of the Company." Result PDF
- Trendlyne
- 5 days 15 hours ago
Between March 18 and March 20, 2026, Gujarat Narmada Valley Fertilizers & Chemicals, the promoter, bought 734,369 equity shares or 1 per cent stake of Gujarat Alkalies via open market purchase.
- Business Standard
- 2 months 1 week ago
Gujarat Alkalies share price today: Toady's rally marked the second consecutive session of gains for Gujarat Alkalies, with the stock rising more than 15 per cent in the period
- Business Standard
- 2 months 2 weeks ago
Gujarat Alkalies & Chemicals Financials
Gujarat Alkalies & Chemicals Technicals
EMA & SMA
- Bearish Moving Average 10
- Bullish Moving Average 6
- 20 Day
- ₹693.88
- 50 Day
- ₹662.37
- 100 Day
- ₹614.74
- 200 Day
- ₹592.00
Resistance and Support
- R3 726.10
- R2 712.55
- R1 691.65
- S1 657.20
- S2 643.65
- S3 622.75
Gujarat Alkalies & Chemicals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-05-29 | Audited Results & Final Dividend | |
| 2026-02-06 | Quarterly Results | |
| 2025-11-07 | Quarterly Results & Others | To consider other business matters. per share(80%)Dividend |
| 2025-08-08 | Quarterly Results & Others | To consider other business matters. per share(80%)Dividend |
| 2025-05-16 | Audited Results & Final Dividend |
About Gujarat Alkalies & Chemicals
- NSE Symbol
- GUJALKALI
- BSE Symbol
- 530001
- Managing Director
- Ms. Avantika Singh Aulakh
- ISIN
- INE186A01019
Similar Stocks to Gujarat Alkalies & Chemicals
Popular Stocks
Gujarat Alkalies & Chemicals FAQs
Gujarat Alkalies & Chemicals share price is ₹670 As on 04 June, 2026 | 06:22
The Market Cap of Gujarat Alkalies & Chemicals is ₹4925.8 Cr As on 04 June, 2026 | 06:22
The P/E ratio of Gujarat Alkalies & Chemicals is -2043.9 As on 04 June, 2026 | 06:22
The PB ratio of Gujarat Alkalies & Chemicals is 0.9 As on 04 June, 2026 | 06:22
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.